Ignite Creation Date:
2025-12-26 @ 11:13 PM
Ignite Modification Date:
2026-03-18 @ 6:22 PM
Study NCT ID:
NCT03845712
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-05-18
First Post:
2019-02-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label Study of Continuation Treatment With Combination Pyrimidine Nucleosides in Patients With TK2 Deficiency
Sponsor:
UCB BIOSCIENCES, Inc.
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Thymidine Kinase 2 Deficiency | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Thymidine Kinase 2 Deficiency | View |
| None | TK2d | View |
| None | mitochondrial disorder | View |
| None | mitochondrial disease | View |
| None | Mitochondria | View |
| None | deoxycytidine and deoxythymidine | View |
| None | doxecitine and doxribtimine | View |
| None | MT1621 | View |
| None | primary mitochondrial myopathy | View |
| None | mitochondrial depletion syndrome | View |
| None | Muscle weakness | View |
| None | Muscle atrophy | View |
| None | Loss of mobility | View |